These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7644296)

  • 1. Cyclosporin A toxicity: MRI appearance of the brain.
    Pace MT; Slovis TL; Kelly JK; Abella SD
    Pediatr Radiol; 1995; 25(3):180-3. PubMed ID: 7644296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical findings and magnetic resonance imaging in severe cyclosporine-related neurotoxicity after allogeneic bone marrow transplantation.
    Trullemans F; Grignard F; Van Camp B; Schots R
    Eur J Haematol; 2001 Aug; 67(2):94-9. PubMed ID: 11722596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurophysiologic evaluation of cyclosporine toxicity associated with bone marrow transplantation.
    Edwards LL; Wszolek ZK; Normand MM
    Acta Neurol Scand; 1995 Nov; 92(5):423-9. PubMed ID: 8610498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central neurotoxicity of cyclosporine in two children with nephrotic syndrome.
    Taque S; Peudenier S; Gie S; Rambeau M; Gandemer V; Bridoux L; Bétrémieux P; De Parscau L; Le Gall E
    Pediatr Nephrol; 2004 Mar; 19(3):276-80. PubMed ID: 14758527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Watershed imaging features and clinical vascular injury in cyclosporin A neurotoxicity.
    Bartynski WS; Grabb BC; Zeigler Z; Lin L; Andrews DF
    J Comput Assist Tomogr; 1997; 21(6):872-80. PubMed ID: 9386275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversible posterior leukoencephalopathy syndrome in a child with cerebral X-linked adrenoleukodystrophy treated with cyclosporine after bone marrow transplantation.
    Chan AK; Bhargava R; Desai S; Joffe A
    J Inherit Metab Dis; 2003; 26(6):527-36. PubMed ID: 14605498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclosporin A acute encephalopathy and seizure syndrome in childhood: clinical features and risk of seizure recurrence.
    Gleeson JG; duPlessis AJ; Barnes PD; Riviello JJ
    J Child Neurol; 1998 Jul; 13(7):336-44. PubMed ID: 9701483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case report: cyclosporin A-induced neurotoxicity.
    Monteiro L; Almeida-Pinto J; Rocha N; Lopes G; Rocha J
    Br J Radiol; 1993 Mar; 66(783):271-2. PubMed ID: 8472124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Etiology of cortical and white matter lesions in cyclosporin-A and FK-506 neurotoxicity.
    Bartynski WS; Zeigler Z; Spearman MP; Lin L; Shadduck RK; Lister J
    AJNR Am J Neuroradiol; 2001; 22(10):1901-14. PubMed ID: 11733324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporine A neurotoxicity among bone marrow transplant recipients.
    Shah AK
    Clin Neuropharmacol; 1999; 22(2):67-73. PubMed ID: 10202600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporin A-induced encephalopathy after allogeneic bone marrow transplantation with prevention of graft-versus-host disease by tacrolimus.
    Takahata M; Hashino S; Izumiyama K; Chiba K; Suzuki S; Asaka M
    Bone Marrow Transplant; 2001 Oct; 28(7):713-5. PubMed ID: 11704797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffusion-weighted MRI in cyclosporin A neurotoxicity for the classification of cerebral edema.
    Debaere C; Stadnik T; De Maeseneer M; Osteaux M
    Eur Radiol; 1999; 9(9):1916-8. PubMed ID: 10602976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurophysiologic evaluation of cyclosporine toxicity associated with bone marrow transplantation.
    Edwards LL; Wszolek ZK; Normand MM
    Acta Neurol Scand; 1996 Nov; 94(5):358-64. PubMed ID: 8947290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Reversible leukoencephalopathy related to cyclosporin treatment].
    Grivé E; Rovira-Cañellas A; Acebedo G; Alvarez-Sabín J
    Rev Neurol; 1997 Mar; 25(139):471-3. PubMed ID: 9147789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporin A-induced ocular flutter after marrow transplantation.
    Apsner R; Schulenburg A; Steinhoff N; Keil F; Janata K; Kalhs P; Greinix H
    Bone Marrow Transplant; 1997 Aug; 20(3):255-6. PubMed ID: 9257896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporine-induced white and grey matter central nervous system lesions in a pediatric renal transplant patient.
    Jeruss J; Braun SV; Reese JC; Guillot A
    Pediatr Transplant; 1998 Feb; 2(1):45-50. PubMed ID: 10084760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurotoxicity after orthotopic liver transplantation. A comparison between cyclosporine and FK506.
    Mueller AR; Platz KP; Bechstein WO; Schattenfroh N; Stoltenburg-Didinger G; Blumhardt G; Christe W; Neuhaus P
    Transplantation; 1994 Jul; 58(2):155-70. PubMed ID: 7518974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversible posterior leucoencephalopathy syndrome associated with bone marrow transplantation.
    Teive HA; Brandi IV; Camargo CH; Bittencourt MA; Bonfim CM; Friedrich ML; de Medeiros CR; Werneck LC; Pasquini R
    Arq Neuropsiquiatr; 2001 Sep; 59(3-B):784-9. PubMed ID: 11593283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MR imaging of reversible cyclosporin A-induced neurotoxicity.
    Truwit CL; Denaro CP; Lake JR; DeMarco T
    AJNR Am J Neuroradiol; 1991; 12(4):651-9. PubMed ID: 1882738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.